The counterfeit blues

September 2007
Marketing Health Services;Fall2007, Vol. 27 Issue 3, p9
Academic Journal
The article reports that in 2007, the Food and Drug Administration (FDA) is cautioning U.S. consumers about the dangers associated with buying prescription drugs over the Internet. The warning comes in light of reports by the FDA that 24 related Web sites might be involved in the distribution of counterfeit prescription drugs. The author reveals that during the spring of 2007, the FDA received information that counterfeit versions of Xenical capsules, a drug manufactured by Hoffmann Laroche Inc., were obtained by 3 consumers from 2 different Web sites. None of the capsules ordered off the Web sites contained orlistat, the active ingredient in authentic versions of Xenical.


Related Articles

  • YOUR DOCTOR IS IN. Manson, JoAnn E. // Glamour;Aug2007, Vol. 105 Issue 8, p94 

    The article focuses on the diet drug Alli. Particular attention is given to a reader who asks if the drug will help them lose weight. The author reports that Alli is an over-the-counter version of a prescription drug called Orlistat that was approved by the U.S. Food and Drug Administration in...

  • Fat Pill for Teens. Gupta, Sanjay; Gajilan, A. Chris // Time International (South Pacific Edition);12/29/2003, Issue 51, p127 

    This article discusses whether the decision of the U.S. Food and Drug Administration (FDA) to approve Xenical, the first obersity drug for adolescents, was good. One of several medications on the market that limit the body's ability to digest fat, Xenical was approved for adults in 1999. In...

  • FDA Actions. Elliott, William T. // Clinical Cardiology Alert;Mar2007, Vol. 26 Issue 3, p2 

    The article reports on a warning issued by the U.S. Food and Drug Administration (FDA) against unsupervised use of topical anesthetic products for cosmetic procedures. Medical care personnel are advised to prescribe topical anesthetics with caution in the lowest concentration consistent with...

  • Crystal structure of the thioesterase domain of human fatty acid synthase inhibited by Orlistat. Pemble, Charles W.; Johnson, Lynnette C.; Kridel, Steven J.; Lowther, W. Todd // Nature Structural & Molecular Biology;Aug2007, Vol. 14 Issue 8, p704 

    Human fatty acid synthase (FAS) is uniquely expressed at high levels in many tumor types. Pharmacological inhibition of FAS therefore represents an important therapeutic opportunity. The drug Orlistat, which has been approved by the US Food and Drug Administration, inhibits FAS, induces tumor...

  • The Bad News About Products "Too Good to Be True".  // Tufts University Health & Nutrition Letter;Sep2009, Vol. 27 Issue 7, p4 

    The article reports on the warning of the U.S. Federal and Drug Administration (FDA) to consumers regarding false advertisements of diet-aid products. It notes that the products promised to help lose weight, boost the immune system and relieve cold symptom. FDA has recalled several products with...

  • Fat-pill risks.  // New Scientist;2/17/2007, Vol. 193 Issue 2591, p4 

    The article discusses the controversy over whether to sell the weight-loss pill orlistat over-the-counter. Drug maker GlaxoSmithKline secured Food and Drug Administration approval to sell the drug, which blocks the absorption of fat into the body. Health advocates fear that those vulnerable to...

  • National trends in the use and costs of anti-obesity medications in England 1998-2005. Janakan Srishanmuganathan; Hitesh Patel; Josip Car; Azeem Majeed // Journal of Public Health;Jun2007, Vol. 29 Issue 2, p199 

    : Background To report the trends in the use and costs of anti-obesity medications in England from 1998 to 2005. : Methods We analysed data on all community anti-obesity drug prescriptions in England collated by the prescription cost analysis system. : Results Between 1998 and 2005, Orlistat...

  • Slim Shady. Park, Jane Shin // Teen Vogue;Nov2009, Vol. 9 Issue 9, p80 

    The article presents information on health risks associated with diet pills. The "Nutrition Business Journal" says that in 2007 alone, consumers purchased 1.67 billion U.S. dollar worth of weight-loss supplements. In 2010, the U.S. Food and Drug Administration (FDA) has found that there are...

  • FDA Fights Fake Meds Online. Ruder, Kate // Diabetes Forecast;Aug2007, Vol. 60 Issue 9, p24 

    The article reports on the warning issued by the U.S. Food and Drug Administration to consumers about the dangers of buying prescription drugs online. The agency had received three reports of counterfeit versions of the weight-loss drug Xenical sold on the Web sites brandpills.com and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics